BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34467676)

  • 1. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
    Liu H; Zhang W; Deng XD; Ma Y; Liu Y
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence.
    Zhang W; Liu H; Deng XD; Ma Y; Liu Y
    Ann Hum Genet; 2020 May; 84(3):259-270. PubMed ID: 31789429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis.
    Malik MA; Zargar SA; Mittal B
    Mol Biol Rep; 2012 Sep; 39(9):9095-104. PubMed ID: 22736108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
    Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
    J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
    Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
    Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
    Malik MA; Zargar SA; Mittal B
    DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
    Yang S; Zhao J; Li L
    Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population.
    Peng XE; Jiang YY; Shi XS; Hu ZJ
    Gene; 2013 May; 521(1):105-10. PubMed ID: 23458878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
    Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
    Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
    Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
    Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of the NQO1 rs1800566 (609C>T) variant with risk of preeclampsia in the Chinese Han population.
    Zhao L; Liu J; Tan P; Zhang W; Gao Q; Li X; Lin Y; Dong Q; Wang H; Liu S
    Pregnancy Hypertens; 2017 Oct; 10():42-45. PubMed ID: 29153688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
    Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
    Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishing a single-tube fluorescent bidirectional PCR method to detect the 609C/T polymorphism of NQO1 gene].
    Ye R; Lai Y; Pan JC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):230-2. PubMed ID: 18393254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Gong M; Yi Q; Wang W
    Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.
    Yu H; Liu H; Wang LE; Wei Q
    PLoS One; 2012; 7(1):e30566. PubMed ID: 22272361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
    Pae CU; Yu HS; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):495-500. PubMed ID: 15151706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner.
    Boroumand M; Pourgholi L; Goodarzynejad H; Ziaee S; Hajhosseini-Talasaz A; Sotoudeh-Anvari M; Mandegary A
    Cardiovasc Toxicol; 2017 Jan; 17(1):35-41. PubMed ID: 26690082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
    Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
    Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.
    Fleming RA; Drees J; Loggie BW; Russell GB; Geisinger KR; Morris RT; Sachs D; McQuellon RP
    Pharmacogenetics; 2002 Jan; 12(1):31-7. PubMed ID: 11773862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.